Zollipak (Lansoprazole) selectively inhibits respiration in
Helicobacter Pylori through decreasing cellular ATP levels.
Why Zollipak (Lansoprazole)?
Zollipak (Lansoprazole) relieves symptoms faster than
other PPIs and has a unique recovery rates: In monotherapy:
H.Pylori eradication rate with Zollipak (Lansoprazole) was:25% to 40% by
30 mg for 4 weeks. In combination with antibiotics:
Zollipak (Lansoprazole) realized up to 92% eradication of H.Pylori.
Zollipak(Lansoprazole) and FDA?
Zollipak (Lansoprazole) only FDA approved in maintenance
therapy of peptic ulcer
Zollipak (Lansoprazole) only FDA approved in NSAIDS-associated gastric
ulcer
